Sale by Dinesh Patel of 75000 shares of Protagonist Therapeutics
| PTGX Stock | USD 41.60 1.10 2.72% |
Slightly above 70 percent of all Protagonist Therapeutics' investors are curious in acquiring. The analysis of the overall investor sentiment regarding Protagonist Therapeutics suggests that a large number of traders are confidant. Protagonist Therapeutics' investing sentiment can be driven by a variety of factors including economic data, Protagonist Therapeutics' earnings reports, geopolitical events, and overall market trends.
Protagonist |
Filed transaction by Protagonist Therapeutics director. General open market or private sale of non-derivative or derivative security
Read at macroaxis.com
Cash Flow Correlation
Protagonist Therapeutics' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Protagonist Therapeutics' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Protagonist Therapeutics Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Protagonist Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Protagonist Therapeutics Fundamental Analysis
We analyze Protagonist Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Protagonist Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Protagonist Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
Protagonist Therapeutics is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Protagonist Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Protagonist Therapeutics stock to make a market-neutral strategy. Peer analysis of Protagonist Therapeutics could also be used in its relative valuation, which is a method of valuing Protagonist Therapeutics by comparing valuation metrics with similar companies.
Peers
Protagonist Therapeutics Related Equities
| XFOR | X4 Pharmaceuticals | 26.42 | ||||
| TERN | Terns Pharmaceuticals | 5.17 | ||||
| BDTX | Black Diamond | 2.09 | ||||
| REPL | Replimune | 1.58 | ||||
| RVMD | Revolution Medicines | 0.53 | ||||
| IDYA | Ideaya Biosciences | 0.14 | ||||
| AKRO | Akero Therapeutics | 1.54 | ||||
| MRUS | Merus BV | 1.83 | ||||
| DAWN | Day One | 1.86 | ||||
| VRNA | Verona Pharma | 1.87 | ||||
| ARVN | Arvinas | 1.95 | ||||
| RNA | Avidity Biosciences | 2.04 | ||||
| PLRX | Pliant Therapeutics | 2.22 | ||||
| KURA | Kura Oncology | 2.28 | ||||
| ABOS | Acumen Pharmaceuticals | 3.56 | ||||
| STOK | Stoke Therapeutics | 3.63 | ||||
| SNDX | Syndax Pharmaceuticals | 3.98 | ||||
| HOOK | Hookipa Pharma | 5.12 | ||||
| RLAY | Relay Therapeutics | 5.74 | ||||
| VTYX | Ventyx Biosciences | 7.64 |
Additional Tools for Protagonist Stock Analysis
When running Protagonist Therapeutics' price analysis, check to measure Protagonist Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagonist Therapeutics is operating at the current time. Most of Protagonist Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagonist Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagonist Therapeutics' price. Additionally, you may evaluate how the addition of Protagonist Therapeutics to your portfolios can decrease your overall portfolio volatility.